HK · Healthcare
Drug Manufacturers - Specialty & Generic
China Shineway Pharmaceutical Group Ltd (2877) is listed on HK in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-05-21, reported market cap is $6.38B, P/E ratio is 5.82, net margin is 30.3%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
China Shineway Pharmaceutical Group Ltd (2877) has a reported market cap of $6.38B (data as of 2026-05-21).
The price-to-earnings (P/E) ratio for China Shineway Pharmaceutical Group Ltd (2877) is 5.82 (data as of 2026-05-21).
Dividend yield is not available in the current snapshot for China Shineway Pharmaceutical Group Ltd (2877). Check the MyAverix Finance app for the latest dividend data.
China Shineway Pharmaceutical Group Ltd (2877) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
2877 is listed on HK.
China Shineway Pharmaceutical Group Ltd (2877) reports a net margin of 30.3% (data as of 2026-05-21).
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.